Company / Net Income
Boston Scientific Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$2.9B
FY2025
5-year range
$698.0M / $4.7B
FY2021-FY2025
Trend
+56.7%
vs FY2024
Sector context
#9 of 164
Health Care
What the data says
Among 164 Health Care companies, Boston Scientific is in the top 5% for net income. Net Income has increased for 3 consecutive years, from $698M in FY2022 to $2.9B in FY2025.
Based on SEC 10-K filings.
$2.9B in FY2025 with a 5-year CAGR of +11.6%. Top quartile in the Health Care sector.
Improved from $1.6B to $2.9B over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +60.6%
- 5-Year CAGR
- +11.6%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 164This company $2.9B Sector average $467.5M
▼
+518.5% above sector average
Key checks
Key Insights
- Boston Scientific's net income has grown for 3 consecutive years.
- 5-year CAGR of +11.6%, indicating consistent growth.
- In FY2025, net income increased 56.7% year-over-year.
- Ranks #9 out of 164 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9B | +56.7% |
| FY2024 | $1.8B | +16.0% |
| FY2023 | $1.6B | +128.1% |
| FY2022 | $698.0M | -85.1% |
| FY2021 | $4.7B | +181.3% |
| FY2020 | $1.7B | -64.4% |
| FY2019 | $4.7B | +181.3% |
| FY2018 | $1.7B | +1506.7% |
| FY2017 | $104.0M | -70.0% |
| FY2016 | $347.0M | +245.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026